Endava’s Growth Potential and Resilience: A Buy Rating Amid Market Challenges

William Blair analyst Maggie Nolan has maintained their bullish stance on DAVA stock, giving a Buy rating on May 20.

Maggie Nolan has given her Buy rating due to a combination of factors that reflect Endava’s potential for growth and resilience in a challenging market environment. The company has demonstrated strong performance in its banking and capital markets segment, which has seen significant year-over-year growth, indicating robust demand for modernization of core systems. Additionally, the healthcare segment has experienced triple-digit growth, largely due to strategic acquisitions that have enhanced Endava’s capabilities.
Despite some challenges in the mobility and payments verticals, management’s optimistic outlook on client sentiment and the expectation of short-lived spending headwinds contribute to a positive assessment. The company’s conservative guidance approach, which accounts only for already contracted revenue, suggests a cautious yet confident stance on future growth. This de-risked outlook, combined with a strong pipeline of large deals, supports the potential for gross margin expansion, reinforcing the Buy rating.

In another report released on May 20, Susquehanna also maintained a Buy rating on the stock with a $42.00 price target.